inibidores da dipeptidil peptidase-iv

Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowerin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JEGANATHA SIVAKUMAR BALASUBRAMANIAN, GOPALAN BALASUBRAMANIAN, AGNEESWARI RAJALINGAM, SHRIDHAR NARAYANAN, FRANKLIN POOPPADY, SIVANESSAN DHARMALINGAM, GAJENDRA SINGH, SUKUMAR SAKAMURI, JAYANARAYAN KULATHINGAL, JEYAMURUGAN MOOKKAN
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JEGANATHA SIVAKUMAR BALASUBRAMANIAN
GOPALAN BALASUBRAMANIAN
AGNEESWARI RAJALINGAM
SHRIDHAR NARAYANAN
FRANKLIN POOPPADY
SIVANESSAN DHARMALINGAM
GAJENDRA SINGH
SUKUMAR SAKAMURI
JAYANARAYAN KULATHINGAL
JEYAMURUGAN MOOKKAN
description Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI1006970A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI1006970A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI1006970A23</originalsourceid><addsrcrecordid>eNrjZFDNzMtMykzJL0otVkhJVEjJLEgtKMlMycxRgDASi1N1M8t4GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8U1CAp6GBgZmluYGjkTFRigCoRygY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>inibidores da dipeptidil peptidase-iv</title><source>esp@cenet</source><creator>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</creator><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</creatorcontrib><description>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150915&amp;DB=EPODOC&amp;CC=BR&amp;NR=PI1006970A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150915&amp;DB=EPODOC&amp;CC=BR&amp;NR=PI1006970A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creatorcontrib><creatorcontrib>GOPALAN BALASUBRAMANIAN</creatorcontrib><creatorcontrib>AGNEESWARI RAJALINGAM</creatorcontrib><creatorcontrib>SHRIDHAR NARAYANAN</creatorcontrib><creatorcontrib>FRANKLIN POOPPADY</creatorcontrib><creatorcontrib>SIVANESSAN DHARMALINGAM</creatorcontrib><creatorcontrib>GAJENDRA SINGH</creatorcontrib><creatorcontrib>SUKUMAR SAKAMURI</creatorcontrib><creatorcontrib>JAYANARAYAN KULATHINGAL</creatorcontrib><creatorcontrib>JEYAMURUGAN MOOKKAN</creatorcontrib><title>inibidores da dipeptidil peptidase-iv</title><description>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDNzMtMykzJL0otVkhJVEjJLEgtKMlMycxRgDASi1N1M8t4GFjTEnOKU3mhNDeDkptriLOHbmpBfnxqcUFicmpeakm8U1CAp6GBgZmluYGjkTFRigCoRygY</recordid><startdate>20150915</startdate><enddate>20150915</enddate><creator>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creator><creator>GOPALAN BALASUBRAMANIAN</creator><creator>AGNEESWARI RAJALINGAM</creator><creator>SHRIDHAR NARAYANAN</creator><creator>FRANKLIN POOPPADY</creator><creator>SIVANESSAN DHARMALINGAM</creator><creator>GAJENDRA SINGH</creator><creator>SUKUMAR SAKAMURI</creator><creator>JAYANARAYAN KULATHINGAL</creator><creator>JEYAMURUGAN MOOKKAN</creator><scope>EVB</scope></search><sort><creationdate>20150915</creationdate><title>inibidores da dipeptidil peptidase-iv</title><author>JEGANATHA SIVAKUMAR BALASUBRAMANIAN ; GOPALAN BALASUBRAMANIAN ; AGNEESWARI RAJALINGAM ; SHRIDHAR NARAYANAN ; FRANKLIN POOPPADY ; SIVANESSAN DHARMALINGAM ; GAJENDRA SINGH ; SUKUMAR SAKAMURI ; JAYANARAYAN KULATHINGAL ; JEYAMURUGAN MOOKKAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI1006970A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</creatorcontrib><creatorcontrib>GOPALAN BALASUBRAMANIAN</creatorcontrib><creatorcontrib>AGNEESWARI RAJALINGAM</creatorcontrib><creatorcontrib>SHRIDHAR NARAYANAN</creatorcontrib><creatorcontrib>FRANKLIN POOPPADY</creatorcontrib><creatorcontrib>SIVANESSAN DHARMALINGAM</creatorcontrib><creatorcontrib>GAJENDRA SINGH</creatorcontrib><creatorcontrib>SUKUMAR SAKAMURI</creatorcontrib><creatorcontrib>JAYANARAYAN KULATHINGAL</creatorcontrib><creatorcontrib>JEYAMURUGAN MOOKKAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JEGANATHA SIVAKUMAR BALASUBRAMANIAN</au><au>GOPALAN BALASUBRAMANIAN</au><au>AGNEESWARI RAJALINGAM</au><au>SHRIDHAR NARAYANAN</au><au>FRANKLIN POOPPADY</au><au>SIVANESSAN DHARMALINGAM</au><au>GAJENDRA SINGH</au><au>SUKUMAR SAKAMURI</au><au>JAYANARAYAN KULATHINGAL</au><au>JEYAMURUGAN MOOKKAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>inibidores da dipeptidil peptidase-iv</title><date>2015-09-15</date><risdate>2015</risdate><abstract>Described are novel compounds of the Formula (I), their derivatives, analogs, tautomeric forms, regioisomers, stereoisomers, polymorphs, solvates, intermediates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, triglyceride levels; treatment of obesity, inflammation, autoimmune diseases such as multiple sclerosis, rheumatoid arthritis; treatment and/or prophylaxis of type II diabetes. These compounds are more particularly dipeptidyl peptidase (DPP IV) inhibitors.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BRPI1006970A2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
title inibidores da dipeptidil peptidase-iv
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T19%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JEGANATHA%20SIVAKUMAR%20BALASUBRAMANIAN&rft.date=2015-09-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI1006970A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true